Your browser doesn't support javascript.
loading
The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia.
Takeda, Reina; Yokoyama, Kazuaki; Ogawa, Miho; Kawamata, Toyotaka; Fukuyama, Tomofusa; Kondoh, Kanya; Takei, Tomomi; Nakamura, Sousuke; Ito, Mika; Yusa, Nozomi; Shimizu, Eigo; Ohno, Nobuhiro; Uchimaru, Kaoru; Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru; Tojo, Arinobu.
  • Takeda R; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yokoyama K; Division of Cellular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Ogawa M; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kawamata T; Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Fukuyama T; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kondoh K; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Takei T; Division of Cellular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Nakamura S; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Ito M; Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yusa N; Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Shimizu E; Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Ohno N; Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Uchimaru K; Department of Applied Genomics, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamaguchi R; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Imoto S; Department of Hematology, Kanto Rosai Hospital, Kanagawa, Japan.
  • Miyano S; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Tojo A; Department of Computational Biology and Medical Science, Laboratory of Tumor Cell Biology, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
Leuk Lymphoma ; 60(11): 2821-2824, 2019 11.
Article en En | MEDLINE | ID: mdl-31058556
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión Oncogénica / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión Oncogénica / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article